Ampliación de Treat It a tratamientos de salud mental
28 Marzo 2024
Grupo Kanabo Plc
("Kanabo", el "Grupo" o la "Compañía")
Expansion of Treat It Clinic to Offer Mental Health Treatments
Kanabo Group plc (LSE: KNB) is pleased to announce the expansion of its online clinic, Treat It, to include specialised mental health treatments. This expansion comes at a time when national mental health infrastructure is under extreme pressure, and this service will allow individuals who are suffering from conditions such as anxiety, PTSD or ADHD to securely access to treatments through the Group's digital health platform.
As with Treat It's existing pain management offering, the mental health service will focus on secondary care, including prescriptions for alternative medications such as medical cannabis. While studies on the efficacy of medical cannabis in this area remain nascent, some evidence indicates that medicinal cannabis may help alleviate symptoms of conditions such as PTSD.
Mental Health in the UK
In 2022, around one in six adults experienced moderate to severe depressive symptoms, an increase from pre-pandemic levels. In the fourth quarter of 2023, around 22% of the adult population experienced a high level of anxiety. The non-profit organisation PTSD Today estimates that around 1 in 10 people in the UK, or around 6.6 million people, might experience PTSD during their lifetime. Meanwhile, mental health services are underserved, with the national situation being described as a crisis or an emergency. This new Clinic offering will provide patients for whom other therapies and medications may not have worked with new opportunities to treat their ailments.
Progression in Line with Half-Year Results
This achievement aligns with the Company's current corporate goals, as laid out in its Half-Year Results (published 29 Sept 2023). In 2024, alongside expanding its secondary care offerings to include specialist mental health services, Kanabo has launched two in-pharmacy clinics (as announced on 15 January 2024) to establish a physical presence for its clinics. The Company plans to continue this momentum by expanding its primary care services and extending its footprint into the EU market in the near future.
Avihu Tamir, CEO, commented: "Since mental health is the second largest indication for medical cannabis prescriptions in the UK, our expansion into these services is poised to significantly increase our patient intake, revolutionising access and treatment options for those in need."
Dr Mehran Afshar, Chief Clinical Director of Treat It, commented: "Mental health is an integral part of overall well-being, yet it often remains overlooked or stigmatised. By expanding our digital health platform to include mental health treatments, we aim to provide patients with access to alternative therapies and raise awareness and destigmatise these conditions. Our multidisciplinary team will work closely with patients to develop personalised treatment plans tailored to their unique needs and circumstances."
Consultas:
Grupo Kanabo plc Avihu Tamir, Director Ejecutivo Assaf Vardimon, director financiero Ian Mattioli, presidente no ejecutivo de la junta
| vía Vigo Consulting 44 0 20 7390 0230 |
Peterhouse Capital Limited (Asesor Financiero y Broker) Eran Zucker / Lucy williams / Carlos Goodfellow
| 44 0 20 7469 0930 |
Vigo Consulting (Relaciones Públicas Financieras/Relaciones con Inversores) Jeremy García / Fiona Hetherington / Verity Snow | 44 0 20 7390 0230 |
Acerca de Kanabo Group plc
Kanabo Group plc (LSE:KNB) es una empresa de salud digital comprometida con transformar la atención al paciente a través de su innovadora plataforma tecnológica y ofertas de tratamientos especializados. Desde su creación en 2017, Kanabo se ha centrado en investigar, desarrollar y comercializar formulaciones reguladas derivadas del cannabis medicinal y dispositivos de inhalación terapéutica.
Kanabo's NHS-approved online telehealth platform, The GP Service, provides patients with video consultations, online prescriptions, and primary care services. Leveraging its telehealth capabilities, in February 2023, Kanabo launched Treat It - an online clinic an online clinic focused on pain management and mental health treatments.
Con sus dos divisiones comerciales complementarias, Kanabo se ha establecido como un proveedor de salud digital de extremo a extremo, que ofrece consultas y recetas de telesalud, además de la entrega de tratamientos personalizados.
La subsidiaria de propiedad parcial de la compañía, Kanabo Agritec Ltd, es una consultoría de cultivo que apoya a las empresas de cannabis en el desarrollo de nuevas granjas a través de infraestructura, investigación y orientación de productos. Estas granjas entregan materias primas de alta calidad para las fórmulas y la línea de productos de Kanabo.
En Kanabo Group Plc, nos dedicamos a brindar a los pacientes tratamientos médicos de la más alta calidad y experiencias de atención médica más accesibles.
RNS puede usar su dirección IP para confirmar el cumplimiento de los términos y condiciones, para analizar cómo interactúa con la información contenida en esta comunicación y para compartir dicho análisis de forma anónima con otros como parte de nuestros servicios comerciales. Para obtener más información sobre cómo RNS y la Bolsa de Valores de Londres utilizan los datos personales que nos proporciona, consulte nuestra Política de privacidad.